V16.F 303.5 (-1.62%)
FR0000031577Drug ManufacturersDrug Manufacturers - General

Virbac (V16.F) Stock Highlights

303.5 | -1.62%
2024-12-21 02:58:54
Virbac SA is a major drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, followed by North America and Latin America. Most of the companys sales are generated from its Companion Animals segment, followed by its Food Producing Animals segment. Veterinarians remain Virbacs main client, yet the companys clients are particularly diverse throughout the world in terms of profession, size and expectations. Virbacs strategy focuses on dominating niche markets while either avoiding or remaining differentiated within the more competitive markets.

Statistics

Range Today
303.5 307
Volume Today 27
Range 1 Year
306.5 392
Volume 1 Year 156
Range 3 Year
220.5 430
Volume 3 Year 1.36K
Range 10 Year
102.479 440.5
Volume 10 Year 6.05K

Highlights

Market Capitalization 3.14B (mid)
Floating Shares 4.11M
Current Price 303.5
Price To Earnings 20.37
Price To Revenue 2.35
Price To Book 2.93
Earnings Per Share 16.84
Dividend Yield 0.38%
Dividend Per Share 1.32
Payout Ratio 7.84%

Performance

Latest -1.62%
1 Month -3.04%
3 Months -22.58%
6 Months -10.74%
1 Year -11.52%
3 Years -25.52%
5 Years +38.27%
10 Years +75.5%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.